United Kingdom· GB-APID-34794011000001101
Iclusig 30mg tablets
A ponatinib product containing ponatinib, registered in United Kingdom by Incyte Biosciences UK Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ponatinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EA05 (ponatinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Ponatinib · ATC L01EA05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ponatinib costs, country by country.
Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ponatinib · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- CH Switzerland$296.54
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ponatinib
- Manufacturer
- Incyte Biosciences UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EA05
- ATC class
- Ponatinib
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin7640159430841
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
500 interactions on record for ponatinib.
Graded by severity as the source publishes them — 166 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ponatinib · interactions on record
500 records
- 166 severe
- 303 moderate
- 31 minor
Most severe, free to view
- LonafarnibA16AX20severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ponatinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesIclusigTakeda Pharmaceuticals America, Inc.
- FinlandIclusigOrifarm Oy
- SwitzerlandIclusig
- CzechiaICLUSIGIncyte Biosciences Distribution B.V., Amsterdam
- NetherlandsIclusig 15 mg, filmomhulde tabletIncyte Biosciences Distribution B.V.
- NorwayIclusigIncyte Biosciences Distribution B.V.
- BelgiumIclusig 15 mgIncyte Biosciences Distribution
- SwedenIclusig 15 mg Filmdragerad tablettIncyte Biosciences Distribution B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Iclusig
- Liechtenstein · Iclusig
- Norway · Iclusig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed39ed33-db6b-4976-b9db-80778614d34c GET /v1/drugs/ed39ed33-db6b-4976-b9db-80778614d34c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34794011000001101",
"desc": "Iclusig 30mg tablets (Incyte Biosciences UK Ltd)",
"form": "Oral tablet",
"vpid": "34819011000001103",
"source": "dmd",
"vtm_id": "777255005",
"strength": "30 mg",
"substance": "Ponatinib",
"ingredient": "Ponatinib hydrochloride",
"supplier_code": "22704211000001101"
}See everything about ponatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.